UNITED STATES NEWS

FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters

Oct 20, 2021, 2:34 PM | Updated: Oct 21, 2021, 6:15 pm

WASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.

The Food and Drug Administration’s decisions mark a big step toward expanding the U.S. booster campaign, which began with extra doses of the Pfizer vaccine last month. But before more people roll up their sleeves, the Centers for Disease Control and Prevention will consult an expert panel Thursday before finalizing official recommendations for who should get boosters and when.

The latest moves would expand by tens of millions the number of Americans eligible for boosters and formally allow “mixing and matching” of shots — making it simpler to get another dose, especially for people who had a side effect from one brand but still want the proven protection of vaccination.

Specifically, the FDA authorized a third Moderna shot for seniors and others at high risk from COVID-19 because of their health problems, jobs or living conditions — six months after their last shot. One big change: Moderna’s booster will be half the dose that’s used for the first two shots, based on company data showing that was plenty to rev up immunity again.

For J&J’s single-shot vaccine, the FDA said all U.S. recipients, no matter their age, could get a second dose at least two months following their initial vaccination.

The FDA rulings differ because the vaccines are made differently, with different dosing schedules — and the J&J vaccine has consistently shown a lower level of effectiveness than either of the two-shot Moderna and Pfizer vaccines.

As for mixing and matching, the FDA said it’s OK to use any brand for the booster regardless of which vaccination people got first. The interchangeability of the shots is expected to speed the booster campaign, particularly in nursing homes and other institutional settings where residents have received different shots over time.

FDA officials said they wanted to make the booster guidance as flexible as possible, given that many people don’t remember which brand of vaccine they received.

“Being able to interchange these vaccines is a good thing — it’s like what we do with flu vaccines,” FDA’s Dr. Peter Marks told reporters Wednesday evening. “Most people don’t know what brand of flu vaccine they received.”

Still, he added that many people will decide to get a booster from the same company as their initial vaccination.

The agency’s mix-and-match decision was based on preliminary results from a government study of different booster combinations that showed an extra dose of any type revs up levels of virus-fighting antibodies. That study also showed recipients of the single-dose J&J vaccination had a far bigger response if they got a full-strength Moderna booster or a Pfizer booster rather than a second J&J shot. The study didn’t test the half-dose Moderna booster.

Health authorities stress that the priority still is getting first shots to about 65 million eligible Americans who remain unvaccinated. But the booster campaign is meant to shore up protection against the virus amid signs that vaccine effectiveness is waning against mild infections, even though all three brands continue to protect against hospitalization and death.

“Today the currently available data suggest waning immunity in some populations of fully vaccinated people,” said FDA’s acting commissioner Dr. Janet Woodcock. “The availability of these authorized boosters is important for continued protection against COVID-19 disease.”

The Moderna booster decision essentially matches FDA’s ruling that high-risk groups are eligible for the Pfizer vaccine, which is made with the same technology.

FDA recommended that everyone who’d gotten the single-shot J&J vaccine get a booster since it has consistently shown lower protection than its two-shot rivals. And several independent FDA advisers who backed the booster decision suggested J&J’s vaccine should have originally been designed to require two doses.

Experts continue to debate the rationale of the booster campaign. Some warn that the U.S. government hasn’t clearly articulated the goals of boosters given that the shots continue to head off the worst effects of COVID-19, and wonder if the aim is to tamp down on virus spread by curbing, at least temporarily, milder infections.

FDA regulators said they would move quickly to expand boosters to lower age groups, such as people in their 40s and 50s, if warranted.

“We are watching this very closely and will take action as appropriate to make sure that the maximum protection is provided to the population,” said Marks, the FDA’s top vaccine official.

In August, the Biden administration announced plans for an across-the-board booster campaign aimed at all U.S. adults, but outside experts have repeatedly argued against such a sweeping effort.

On Thursday an influential panel convened by the CDC is expected to offer more specifics on who should get boosters and when. Their recommendations are subject to approval by the CDC director.

The vast majority of the nearly 190 million Americans who are fully vaccinated against COVID-19 have received the Pfizer or Moderna options, while about 15 million have received the J&J vaccine.

___

Associated Press writer Mike Stobbe contributed to this story from New York.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Lifetime Windows & Doors

United States News

FILE - Singer Celine Dion performs during her Courage tour in Quebec City on Sept. 18, 2019. Dion h...
Associated Press

Celine Dion cancels shows because of stiff person syndrome

Celine Dion has put a halt on all performing after being diagnosed with a rare neurological disorder. In an emotional video messages posted in French and English on Thursday on Instagram, Dion said stiff person syndrome was causing spasms that affect her ability to walk and sing. “Unfortunately, the spasms affect every aspect of my […]
1 day ago
Supporters hold up signs reading "Bring Brittney Home" during a rally to support the release of det...
KTAR.com

Arizona politicians react to news of Phoenix WNBA star Brittney Griner’s release

News of Phoenix Mercury star Brittney Griner’s release from a Russian prison was welcomed by political leaders in Arizona.
1 day ago
(AP Photo/Eric Gay, File)...
Associated Press

House sends bill protecting same-sex, interracial marriages to Biden

The bill requires all states to recognize legal marriages regardless of “sex, race, ethnicity or national origin.”
1 day ago
House Minority Leader Kevin McCarthy of Calif., departs after speak during a Congressional Gold Med...
Associated Press

Congress set to rescind COVID-19 vaccine mandate for troops

WASHINGTON (AP) — The COVID-19 vaccine mandate for members of the U.S. military would be rescinded under the annual defense bill heading for a vote this week in Congress, ending a directive that helped ensure the vast majority of troops were vaccinated but also raised concerns that it harmed recruitment and retention. Republicans, emboldened by […]
2 days ago
FILE - Light illuminates part of the Supreme Court building at dusk on Capitol Hill in Washington, ...
Associated Press

Justices skeptical of elections case that could alter voting

WASHINGTON (AP) — At least six Supreme Court justices sound skeptical of making a broad ruling that would leave state legislatures virtually unchecked when making rules for elections for Congress and the presidency. In arguments Wednesday, both liberal and conservative members of the high court appeared to take issue with the main thrust of a […]
2 days ago
Blue Bunny and Halo Top brand ice cream products are seen in Englewood, N.J., The Italian confectio...
Associated Press

Ferrero buys Blue Bunny ice cream maker Wells Enterprises

Italian confectioner Ferrero said Wednesday it is acquiring Wells Enterprises, one of the largest U.S. ice cream makers, in a deal that will broaden both companies’ offerings. Wells, a 100-year-old family-owned company based in Le Mars, Iowa, makes Blue Bunny, Halo Top and other brands. It employs 4,000 people and produces more than 200 million […]
2 days ago

Sponsored Articles

...
Quantum Fiber

How high-speed fiber internet edges out cable for everyday use

In a world where technology drives so much of our daily lives, a lack of high-speed internet can be a major issue.
(Photo via MLB's Arizona Fall League / Twitter)...
Arizona Fall League

Top prospects to watch at this year’s Arizona Fall League

One of the most exciting elements of the MLB offseason is the Arizona Fall League, which began its 30th season Monday.
...
Children’s Cancer Network

Children’s Cancer Network celebrates cancer-fighting superheroes, raises funds during September’s Childhood Cancer Awareness Month

Jace Hyduchak was like most other kids in his kindergarten class: He loved to play basketball, dress up like his favorite superheroes and jump as high as his pint-sized body would take him on his backyard trampoline.
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters